<p>The present invention relates to compounds and pharmaceutically acceptable salts of formula: (I) which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosine phosphatase (PTP-1B) that are useful in the treatment of diabetes and other PTP-1B mediated diseases, such as cancer, neurodegenerative diseases and the like. The compounds of the invention are also useful in pharmaceutical compositions and methods of treating the aforementioned conditions.</p>
申请公布号
WO2006050097(A1)
申请公布日期
2006.05.11
申请号
WO2005US38939
申请日期
2005.10.28
申请人
THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC;VAN ZANDT, MICHAEL, C.;FANG, HAIQUAN;HU, SHAOJING;WHITEHOUSE, DARREN
发明人
VAN ZANDT, MICHAEL, C.;FANG, HAIQUAN;HU, SHAOJING;WHITEHOUSE, DARREN